Halozyme Therapeutics, Inc. (LON:0J2O)

Halozyme Therapeutics Statistics

Total Valuation

LON:0J2O has a market cap or net worth of GBP 6.50 billion. The enterprise value is 7.23 billion.

Market Cap	6.50B
Enterprise Value	7.23B

Important Dates

The next estimated earnings date is Tuesday, November 4, 2025.

Earnings Date	Nov 4, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	116.97M
Shares Outstanding	n/a
Shares Change (YoY)	-2.50%
Shares Change (QoQ)	-1.96%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	115.52M

Valuation Ratios

The trailing PE ratio is 15.98 and the forward PE ratio is 10.23.

PE Ratio	15.98
Forward PE	10.23
PS Ratio	7.56
PB Ratio	26.77
P/TBV Ratio	n/a
P/FCF Ratio	16.47
P/OCF Ratio	16.26
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.85, with an EV/FCF ratio of 18.31.

EV / Earnings	17.77
EV / Sales	8.37
EV / EBITDA	12.85
EV / EBIT	14.45
EV / FCF	18.31

Financial Position

The company has a current ratio of 8.36, with a Debt / Equity ratio of 4.62.

Current Ratio	8.36
Quick Ratio	6.44
Debt / Equity	4.62
Debt / EBITDA	2.00
Debt / FCF	2.84
Interest Coverage	37.96

Financial Efficiency

Return on equity (ROE) is 179.14% and return on invested capital (ROIC) is 23.10%.

Return on Equity (ROE)	179.14%
Return on Assets (ROA)	21.21%
Return on Invested Capital (ROIC)	23.10%
Return on Capital Employed (ROCE)	35.56%
Revenue Per Employee	2.46M
Profits Per Employee	1.16M
Employee Count	350
Asset Turnover	0.59
Inventory Turnover	1.56

Taxes

In the past 12 months, LON:0J2O has paid 98.43 million in taxes.

Income Tax	98.43M
Effective Tax Rate	19.48%

Stock Price Statistics

The stock price has increased by +20.61% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+20.61%
50-Day Moving Average	65.90
200-Day Moving Average	58.36
Relative Strength Index (RSI)	72.26
Average Volume (20 Days)	1,246

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.42

Income Statement

In the last 12 months, LON:0J2O had revenue of GBP 860.31 million and earned 406.76 million in profits. Earnings per share was 3.19.

Revenue	860.31M
Gross Profit	666.68M
Operating Income	498.28M
Pretax Income	505.18M
Net Income	406.76M
EBITDA	553.70M
EBIT	498.28M
Earnings Per Share (EPS)	3.19

Balance Sheet

The company has 400.11 million in cash and 1.12 billion in debt, giving a net cash position of -722.52 million.

Cash & Cash Equivalents	400.11M
Total Debt	1.12B
Net Cash	-722.52M
Net Cash Per Share	n/a
Equity (Book Value)	242.87M
Book Value Per Share	2.06
Working Capital	721.43M

Cash Flow

In the last 12 months, operating cash flow was 399.82 million and capital expenditures -5.17 million, giving a free cash flow of 394.65 million.

Operating Cash Flow	399.82M
Capital Expenditures	-5.17M
Free Cash Flow	394.65M
FCF Per Share	n/a

Margins

Gross margin is 77.49%, with operating and profit margins of 57.92% and 47.28%.

Gross Margin	77.49%
Operating Margin	57.92%
Pretax Margin	58.72%
Profit Margin	47.28%
EBITDA Margin	64.36%
EBIT Margin	57.92%
FCF Margin	45.87%

Dividends & Yields

LON:0J2O does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.50%
Shareholder Yield	n/a
Earnings Yield	6.26%
FCF Yield	6.07%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0J2O has an Altman Z-Score of 4.94 and a Piotroski F-Score of 6.

Altman Z-Score	4.94
Piotroski F-Score	6